Bluesight Introduces ShortageCheck to Combat Drug Shortages
New technology empowers healthcare systems with proactive measures against drug shortages.
Bluesight, known for its innovative hospital intelligence solutions, has rolled out ShortageCheck, a pivotal technology aimed at aiding hospitals and health systems in predicting and managing drug shortages effectively. This powerful platform combines advanced predictive analytics, current inventory data, and collaborative planning functionalities to address potential disruptions before they impact patient care.
The emergence of ShortageCheck is particularly timely as recent reports indicate that 75% of healthcare professionals view drug shortages as one of their chief concerns that hinder efficiency and compliance. Moreover, research highlights a staggering rise in the time and expenses associated with managing these shortages—an increase that has seen costs soar to nearly $900 million annually.
ShortageCheck provides real-time monitoring capabilities, tracking over 20 critical market indicators, including shifts in demand and fulfillment challenges across over 2,500 hospitals. The system not only identifies early warning signs of potential drug shortages but also forecasts these shortages, providing crucial lead times of up to 90 days, with an average of 42 days. Such foresight equips hospitals and health systems with the necessary time to devise plans and avert interruptions in patient care.
Kevin MacDonald, CEO and co-founder of Bluesight, emphasizes the importance of this innovation, stating, "Shortage management has become a significant pain point for our clients. When faced with unexpected shortages, hospital teams are often left scrambling for solutions, which ultimately jeopardizes patient care. By launching ShortageCheck, we are addressing this issue head-on, allowing healthcare providers to manage their resources efficiently, especially in a climate of rising drug costs and persistent staff shortages."
ShortageCheck expands Bluesight's comprehensive suite of Hospital Intelligence solutions, which aims to simplify complex healthcare operations. Other offerings such as KitCheck, CostCheck, and 340BCheck complement ShortageCheck, enabling clients to restock inventory faster, cut unnecessary spending, and streamline audit preparations significantly.
For hospitals seeking to improve their operations and mitigate the risks associated with drug shortages, Bluesight offers a suite of intelligent solutions, which include tools that enable more efficient inventory management and compliance. With a commitment to protecting patient safety and optimizing financial resources, Bluesight asserts that over 2,400 hospitals in both the United States and Canada trust them to enhance their operational capabilities daily.
For additional details on ShortageCheck and how it can transform hospital drug inventory management, visit Bluesight's website.
Frequently Asked Questions
What is ShortageCheck?
ShortageCheck is Bluesight's innovative solution designed to help hospitals predict and manage drug shortages before they impact patient care.
How does ShortageCheck work?
The platform continuously analyzes more than 20 market indicators to forecast potential drug shortages, giving hospitals ample time to prepare.
Why are drug shortages a significant concern for hospitals?
Drug shortages can severely affect patient care and operational efficiency, leading to increased costs and complexities in managing inventories.
What are some additional tools offered by Bluesight?
Along with ShortageCheck, Bluesight provides solutions like KitCheck, CostCheck, and 340BCheck, aimed at improving various aspects of hospital operations.
How many hospitals rely on Bluesight solutions?
Over 2,400 hospitals in the United States and Canada depend on Bluesight for efficient inventory management and operational safety.
